Annexin A1 in malignant tumors: Current opinions and controversies

International Journal of Biological Markers

Volumn 29, Issue 1, 2014, Pages

  Biaoxue, Rong ^a   Xiguang, Cai ^b   Shuanying, Yang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Annexin A1; Biomarker; Cancer; Signal pathway; Tumor

Indexed keywords

ASPARAGINE; CHEMOKINE RECEPTOR CXCR4; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ RECEPTOR; LIPOCORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR Y; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C; SCATTER FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CELL DEATH; COLORECTAL CANCER; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS CARCINOMA; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANNEXIN A1; APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84897856499     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000046     Document Type: Article

References (73)

1. Lim LHK, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007; 21: 968-75.
2. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82: 331-71.
3. Perretti M, Dalli J. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol 2009; 158: 936-46.
4. D'Acquisto F, Perretti M, Flower RJ. Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol 2008; 155: 152-69.
5. Taylor AD, Cowell AM, Flower J, Buckingham JC. Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 1993; 58: 430-9.
6. Buckingham JC, John CD, Solito E, et al. Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci 2006; 1088: 396-409.
7. Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6: 449-61.
8. Yom CK, Han W, Kim SW, et al. Clinical significance of annexin A1 expression in breast cancer. J Breast Cancer 2011; 14: 262-8.
9. Wang LP, Bi J, Yao C, et al. Annexin A1 expression and its prognostic significance in human breast cancer. Neoplasma 2010; 57: 253-9.
10. Cao Y, Li Y, Edelweiss M, et al. Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol 2008; 16: 530-4.
11. Shen D, Chang HR, Chen Z, et al. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 2005; 326: 218-27.
12. Yu G, Wang J, Chen Y, et al. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis 2008; 25: 695-702.
13. Paweletz CP, Ornstein DK, Roth MJ, et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000; 60: 6293-7.
14. Hu N, Flaig MJ, Su H, et al. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10: 6013-22.
15. Xia SH, Hu LP, Hu H, et al. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 2002; 21: 6641-8.
16. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002; 8: 117-23.
17. Smitherman AB, Mohler JL, Maygarden SJ, Ornstein DK. Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J Urol 2004; 171: 916-20.
18. Patton KT, Chen HM, Joseph L, Yang XJ. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 2005; 47: 597-601.
19. Xiao GS, Jin YS, Lu QY, et al. Annexin-I as a potential target for green tea extract induced actin remodeling. Int J Cancer 2007; 120: 111-20.
20. Garcia Pedrero JM, Fernandez MP, Morgan RO, et al. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004; 164: 73-9.
21. Alves VA, Nonogaki S, Cury PM, et al. Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. Histopathology 2008; 53: 715-27.
22. Silistino-Souza R, Rodrigues-Lisoni FC, Cury PM, et al. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer 2007; 120: 2582-9.
23. Zhang L, Yang X, Zhong LP, et al. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 362-70.
24. Faria PC, Sena AA, Nascimento R, et al. Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients. Oral Oncol 2010; 46: 25-30.
25. Rodrigo JP, Garcia-Pedrero JM, Llorente JL, et al. Downregulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas. Hum Pathol 2011; 42: 88-94.
26. Wang D, Zhang H, Fang Z, Yu G. Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma. Eur Surg Res 2010; 45: 151-7.
27. Petrella A, Festa M, Ercolino SF, et al. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther 2006; 5: 643-7.
28. Su N, Xu XY, Chen H, et al. Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer. Tohoku J Exp Med 2010; 222: 243-50.
29. Brichory FM, Misek DE, Yim AM, et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 2001; 98: 9824-9.
30. Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Clin Exp Metastasis 2011; 28: 413-25.
31. Qiu J, Choi G, Li L, et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 2008; 26: 5060-6.
32. Ahn SH, Sawada H, Ro JY, Nicolson GL. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 1997; 15: 151-6.
33. Bist P, Leow SC, Phua QH, et al. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasis. Oncogene 2011; 30: 3174-85.
34. Bai XF, Ni XG, Zhao P, et al. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004; 10: 1466-70.
35. Liu Q, Wang CF, Zhou Z, et al. Expression of annexin I in human pancreatic cancer and the influence of its downregulation on biology of this cancer. Zhonghua Zhong Liu Za Zhi 2007; 29: 738-41.
36. Robinson-Bennett BL, Deford J, Diaz-Arrastia C, et al. Implications of tyrosine phosphoproteomics in cervical carcinogenesis. J Carcinog 2008; 7: 2.
37. Cui L, Wang Y, Shi Y, et al. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer. Proteomics 2007; 7: 4192-202.
38. Zimmermann U, Woenckhaus C, Teller S, et al. Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumor stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. Histol Histopathol 2007; 22: 527-34.
39. Mulla A, Christian HC, Solito E, Mendoza N, Morris JF, Buckingham JC. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf) 2004; 60: 107-19.
40. Masaki T, Tokuda M, Ohnishi M, et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24: 72-81.
41. Yang LP, Yang ZL, Tan XG, Miao XY. Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder. Zhonghua Zhong Liu Za Zhi 2010; 32: 595-9.
42. Protzel C, Richter M, Poetsch M, et al. The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas. World J Urol 2011; 29: 393-8.
43. Falini B, Tiacci E, Liso A, et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004; 363: 1869-70.
44. Pencil SD, Toth M. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Clin Exp Metastasis 1998; 16: 113-21.
45. Biaoxue R, Xiling J, Shuanying Y, et al. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients. J Exp Clin Cancer Res 2012; 31: 70.
46. Shen D, Nooraie F, Elshimali Y, et al. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006; 37: 1583-91.
47. Yang Y, Liu Y, Yao X, et al. Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol 2011; 179: 1504-12.
48. Maschler S, Gebeshuber CA, Wiedemann EM, et al. Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med 2010; 2: 401-14.
49. de Graauw M, van Miltenburg MH, Schmidt MK, et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 2010; 107: 6340-5.
50. Yi M, Schnitzer JE. Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci U S A 2009; 106: 17886-91.
51. Liu Q, Hu H, Ran YL, et al. In vivo effect of annexin I downregulation on the growth of human pancreatic cancer in nude mice. Zhonghua Zhong Liu Za Zhi 2008; 30: 897-900.
52. Rondepierre F, Bouchon B, Papon J, et al. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta 2009; 1794: 61-9.
53. Babbin BA, Lee WY, Parkos CA, et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 2006; 281: 19588-99.
54. de Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 2000; 31: 371-80.
55. Tabe Y, Jin L, Contractor R, et al. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ 2007; 14: 1443-56.
56. Hsiang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006; 66: 1413-24.
57. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-78.
58. Alldridge LC, Harris HJ, Plevin R, Hannon R, Bryant CE. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. Journal of Biological Chemistry 1999; 274: 37620-8.
59. Alldridge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Experimental cell research 2003; 290: 93-107.
60. Khau T, Langenbach SY, Schuliga M, et al. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. The FASEB Journal 2011; 25: 483-96.
61. Inokuchi J, Lau A, Tyson DR, Ornstein DK. Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. Carcinogenesis 2009; 30: 1082-8.
62. Lecona E, Barrasa JI, Olmo N, Llorente B, Turnay J, Lizarbe MA. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. Mol Cell Biol 2008; 28: 4665-74.
63. Fava RA, Cohen S. Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J Biol Chem 1984; 259: 2636-45.
64. Cicek M, Samant RS, Kinter M, Welch DR, Casey G. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasissuppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 2004; 21: 149-57.
65. D'Acunto CW, Fontanella B, Rodriquez M, Taddei M, Parente L, Petrella A. Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1. Cancer Lett 2010; 295: 85-91.
66. Gou LT, Tong AP, Yan F, et al. Altered protein-expressing profile in hPNAS4-induced apoptosis in A549 human lung adenocarcinoma cells. J Cell Biochem 2009; 108: 1211-9.
67. Wu YL, Jiang XR, Lillington DM, Newland AC, Kelsey SM. Upregulation of lipocortin 1 inhibits tumor necrosis factorinduced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance. Br J Haematol 2000; 111: 807-16.
68. Zhang Z, Huang L, Zhao W, Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 2010; 70: 2379-88.
69. Cote MC, Lavoie JR, Houle F, Poirier A, Rousseau S, Huot J. Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM kinase 1-mediated phosphorylation of annexin 1. J Biol Chem 2010; 285: 8013-21.
70. Salles JP, Netelenbos JC, Slootweg MC. Growth hormone induces tyrosine phosphorylation of annexin I in rat osteosarcoma cells. Endocrinology 1996; 137: 4358-62.
71. Wang Y, Serfass L, Roy MO, Wong J, Bonneau AM, Georges E. Annexin-I expression modulates drug resistance in tumor cells. Biochem Biophys Res Commun 2004; 314: 565-70.
72. Carollo M, Parente L, D'Alessandro N. Dexamethasoneinduced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1. Oncology research 1998; 10: 245-54.
73. Zhu F, Wang Y, Zeng S, Fu X, Wang L, Cao J. Involvement of Annexin A1 in Multidrug Resistance of K562/ADR Cells Identified by the Proteomic Study. Omics-a Journal of Integrative Biology 2009; 13: 467-76.